Efficacy and safety of liraglutide 3.0 mg in individuals with overweight or obesity and type 2 diabetes treated with basal insulin: the SCALE insulin randomized …

WT Garvey, AL Birkenfeld, D Dicker, G Mingrone… - Diabetes …, 2020 - Am Diabetes Assoc
OBJECTIVE Most individuals with type 2 diabetes also have obesity, and treatment with
some diabetes medications, including insulin, can cause further weight gain. No approved …

Efficacy and safety of liraglutide 3.0 mg in individuals with overweight or obesity and type 2 diabetes treated with basal insulin: The SCALE insulin randomized …

WT Garvey, AL Birkenfeld, D Dicker, G Mingrone… - DIABETES …, 2020 - publicatt.unicatt.it
OBJECTIVE Most individuals with type 2 diabetes also have obesity, and treatment with
some diabetes medications, including insulin, can cause further weight gain. No approved …

Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized …

WT Garvey, AL Birkenfeld, D Dicker, G Mingrone… - Diabetes …, 2020 - europepmc.org
Objective Most individuals with type 2 diabetes also have obesity, and treatment with some
diabetes medications, including insulin, can cause further weight gain. No approved chronic …

[HTML][HTML] Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin …

WT Garvey, AL Birkenfeld, D Dicker, G Mingrone… - Diabetes …, 2020 - ncbi.nlm.nih.gov
OBJECTIVE Most individuals with type 2 diabetes also have obesity, and treatment with
some diabetes medications, including insulin, can cause further weight gain. No approved …

Efficacy and safety of liraglutide 3.0 mg in individuals with overweight or obesity and type 2 diabetes treated with basal insulin: The SCALE insulin randomized …

WT Garvey, AL Birkenfeld, D Dicker, G Mingrone… - Diabetes …, 2020 - kclpure.kcl.ac.uk
OBJECTIVE Most individuals with type 2 diabetes also have obesity, and treatment with
some diabetes medications, including insulin, can cause further weight gain. No approved …

Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized …

WT Garvey, AL Birkenfeld, D Dicker, G Mingrone… - 2020 - pubmed.ncbi.nlm.nih.gov
Objective Most individuals with type 2 diabetes also have obesity, and treatment with some
diabetes medications, including insulin, can cause further weight gain. No approved chronic …

[引用][C] Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin …

WT Garvey, AL Birkenfeld, D Dicker… - Diabetes …, 2020 - tobias-lib.ub.uni-tuebingen.de
Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2
Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial Efficacy …

[引用][C] Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin …

WT Garvey, AL Birkenfeld, D Dicker… - Diabetes …, 2020 - ub01.uni-tuebingen.de
Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2
Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial Efficacy …